Preventing infection at the source
Light with Clinical Impact
Lindo Life Science is a clinical lighting disinfection technology redefining infection control by shifting healthcare from reactive treatment to continuous prevention.
Preventing infection at the source
Light with Clinical Impact
Lindo Life Science is a clinical lighting disinfection technology redefining infection control by
shifting healthcare from reactive treatment to continuous prevention.
Advancing infection prevention
Lindo Life Science embeds antimicrobial technology into existing healthcare infrastructure to deliver autonomous, continuous infection prevention.
The medical technologies that Lindo has created target bacteria at the source where biofilm forms with continuous, in-system protection to reduce infection risk and improve patient outcomes without chemicals or disruption to care.
Our mission is to create a future where infection prevention is built into healthcare systems as a global standard to improve patient outcomes at scale and reduce reliance on treatment.
Why healthcare must change
Healthcare associated infections (HAIs) including ventilator associated pneumonia (VAP) remain one of the most significant challenges facing modern medicine, particularly with the rise of Antimicrobial Resistance (AMR).
There are more than 2 million HAIs and 75,000 VAP cases that contribute to an annual economic burden of US$28 billion per year in the US alone.
Currently, the healthcare system’s reactive model manages infection after it forms. It is labour intensive, relies on chemicals and contributes to AMR and environmental burden.
Lindo Life Science aims to reset the healthcare system with preventative and proactive measures that control infection at the source without contributing to AMR.
Stop infection where it starts
Lindo Life Science’s purpose-built solutions enable system-wide infection prevention.
From airways to drainage systems, Lindo enables continuous, in-system protection by embedding aBL technology into existing healthcare infrastructure.
This enables continuous disinfection without reliance on chemical use, manual processes or disruption to delivery of patient care.
Anesthesiologist & Critical Care Specialist
"The potential impact of the Lindo Endotracheal Tube (ETT) cannot be overstated. VAP remains a significant challenge in critical care, leading to prolonged hospital stays, increased morbidity, mortality, and substantial healthcare costs. Current preventive measures, while effective to some degree, have not fully addressed this issue."
What is antimicrobial blue light technology?
Antimicrobial blue light (aBL) is a non-chemical disinfection technology proven to neutralise bacteria, mould and many viruses without contributing to antimicrobial resistance.
aBL operates within the visible light spectrum (405 and 470 nanometres) and activates naturally occurring molecules within microorganisms that produce reactive oxygen species, which damage and inactivate biolfilm.
Advances in LED technology have made it possible to deliver targeted, high intensity blue light safely and reliably within medical and healthcare applications.
Lindo Life Science applies this technology to deliver autonomous, continuous infection prevention at the source.
Validated by leading healthcare & industry partners















For workforce
- Address risk of infection
- Improve health, safety & wellbeing
- Do not disrupt workflow

For healthcare
- Protect patients & workforce
- Embed into existing infrastructure
- Reduce environmental impact

For facilities
- Autonomous, always-on disinfection
- Control contamination
- Reduce chemical use & manual labour

For patients / casualties
- Improve comfort & wellbeing
- Enhance patient outcomes
- Fast-track recovery

For investors
- Versatile, scalable platform
- Secure IP
- Enable system-wide shift
Light with clinical impact
Lindo Life Science presents a unique investment opportunity to create a significant impact.
By solving a critical healthcare challenge at scale, Lindo Life Science will create a novel clinical
and operational solution with no barriers to global markets and significant commercial value.
The potential benefits of Lindo Life Science are far-reaching with its solutions improving the lives of healthcare workforce, patients and facility operators worldwide.
Join us on the journey
Be a part of category-defining platform shifting healthcare from reactive treatment to continuous prevention at the source.
